AYOXXA: Funding, Investors & Team (Sep 2026)
AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.
AYOXXA has raised $100k across 1 funding round on record, the most recent an undisclosed round of $100k announced in Mar 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AYOXXA Company Profile and Key Stats
Latest funding round on record: Mar 2022.
AYOXXA Funding Rounds
AYOXXA Founders and Leadership Team
No contact details are on record for this team yet.
AYOXXA Funding Compared to Other Biotechnology Startups
AYOXXA's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AYOXXA in Biotechnology and Cologne
Companies Similar to AYOXXA
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
AYOXXA Funding FAQs
What does AYOXXA do?
AYOXXA is a biotech company commercializing innovative technology developed at the National University of Singapore (NUS). AYOXXA’s patented technology platform is producing a new generation of biochips – merging biology with IT. This allows the biochip to accumulate large numbers of applications – measuring multiple protein markers for cancer, allergies, cardiovascular and infectious diseases – in a single test.
How much funding has AYOXXA raised?
AYOXXA has raised $100k across 1 round on record. The most recent is an undisclosed round of $100k announced in Mar 2022.
When did AYOXXA last raise funding?
AYOXXA's most recent funding round on record is an undisclosed round of $100k, announced in Mar 2022.
Who is the CEO of AYOXXA?
Wolfgang Kintzel is listed as CEO at AYOXXA.
Where is AYOXXA headquartered?
AYOXXA is based in Cologne, Nordrhein-Westfalen, Germany.
How many employees does AYOXXA have?
AYOXXA is in the 11-50 employee band.
How does AYOXXA's funding compare to other Biotechnology startups?
AYOXXA's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's AYOXXA Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AYOXXA is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.